CA1182049A - Apap antacid composition - Google Patents

Apap antacid composition

Info

Publication number
CA1182049A
CA1182049A CA000388485A CA388485A CA1182049A CA 1182049 A CA1182049 A CA 1182049A CA 000388485 A CA000388485 A CA 000388485A CA 388485 A CA388485 A CA 388485A CA 1182049 A CA1182049 A CA 1182049A
Authority
CA
Canada
Prior art keywords
apap
tablet
antacid
tablets
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000388485A
Other languages
English (en)
French (fr)
Inventor
Francis J. Sterbenz
Leonard Weintraub
George L. Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of CA1182049A publication Critical patent/CA1182049A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000388485A 1981-07-13 1981-10-22 Apap antacid composition Expired CA1182049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28256581A 1981-07-13 1981-07-13
US282,565 1981-07-13

Publications (1)

Publication Number Publication Date
CA1182049A true CA1182049A (en) 1985-02-05

Family

ID=23082085

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000388485A Expired CA1182049A (en) 1981-07-13 1981-10-22 Apap antacid composition

Country Status (17)

Country Link
JP (1) JPS5823617A (ja)
KR (1) KR840000234A (ja)
AR (1) AR228661A1 (ja)
AU (1) AU8436082A (ja)
BE (1) BE893827A (ja)
CA (1) CA1182049A (ja)
DE (1) DE3226178A1 (ja)
DK (1) DK309282A (ja)
FR (1) FR2509174A1 (ja)
GB (1) GB2103087A (ja)
GR (1) GR76197B (ja)
IT (1) IT1148199B (ja)
NL (1) NL8202773A (ja)
NO (1) NO822385L (ja)
PT (1) PT75234B (ja)
SE (1) SE8204288L (ja)
ZA (1) ZA823760B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
WO1998032434A1 (en) * 1997-01-29 1998-07-30 Chong Kun Dang Corp. New analgesic composition
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
BRPI0520000A2 (pt) * 2004-10-28 2009-04-07 Novartis Ag composição compreendendo acetaminofeno, cafeìna e opcionalmente aspirina juntos com um agente alcalino para absorção intensificada
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
GB1221038A (en) * 1969-09-18 1971-02-03 H & T Kirby & Company Ltd Improvements in effervescent tablet compositions
GB1359614A (en) * 1971-04-06 1974-07-10 Dev Et De Rech Soc Fr De Method for the manufacture of effervescent tablets

Also Published As

Publication number Publication date
AU8436082A (en) 1983-01-20
PT75234A (en) 1982-08-01
IT1148199B (it) 1986-11-26
NL8202773A (nl) 1983-02-01
DE3226178A1 (de) 1983-01-20
NO822385L (no) 1983-01-14
FR2509174A1 (fr) 1983-01-14
KR840000234A (ko) 1984-02-18
BE893827A (fr) 1983-01-12
AR228661A1 (es) 1983-03-30
SE8204288L (sv) 1983-01-14
GR76197B (ja) 1984-08-03
DK309282A (da) 1983-01-14
PT75234B (en) 1985-10-04
JPS5823617A (ja) 1983-02-12
GB2103087A (en) 1983-02-16
ZA823760B (en) 1983-03-30
SE8204288D0 (sv) 1982-07-12
IT8248788A0 (it) 1982-07-09

Similar Documents

Publication Publication Date Title
US4556678A (en) Sustained release propranolol tablet
US5200193A (en) Pharmaceutical sustained release matrix and process
US5004613A (en) Oral sustained release pharmaceutical formulation and process
US4820522A (en) Oral sustained release acetaminophen formulation and process
KR19980702370A (ko) 염기성 물질로 안정화된 약제학적 조성물
JPH07558B2 (ja) モピダモール製剤
WO1988008299A1 (en) Pharmaceutical sustained release matrix and process
CN100389751C (zh) 含扑热息痛的吞咽片剂
JP2931409B2 (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
KR20030009440A (ko) 조성물
US4049803A (en) Augmentation of blood levels of aspirin
CA1182049A (en) Apap antacid composition
US7993673B2 (en) Swallow tablet comprising paracetamol
JPH0428685B2 (ja)
EP1353650A2 (en) Process for preparing non-hygroscopic sodium valproate composition
JPH0529205B2 (ja)
SU1009467A1 (ru) Средство дл растворени мочевых конкрементов
RU2240784C1 (ru) Лекарственное средство на основе арбидола
CA1334933C (en) Pharmaceutical composition and process for its preparation
JPH0656677A (ja) 制酸剤組成物
GB2061111A (en) Long acting pharmaceutical composition
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
JPS6024766B2 (ja) 徐放性抗生物質錠
JPS6360926A (ja) 感冒薬
JPH02282322A (ja) 有効物質の浸食制御による放出システムおよびその製造方法

Legal Events

Date Code Title Description
MKEX Expiry